Hashimoto's and GLP-1 medications: Why losing weight can change the thyroid medication dose you need
Some people taking a GLP-1 medication who also take thyroid medication describe symptoms such as fatigue, constipation, feeling cold, hair thinning and stalled weight loss. This can result in self-questioning that is difficult to answer without looking further: Is it the GLP-1 medication or is it my thyroid?
Many of these patients have Hashimoto's thyroiditis, an autoimmune condition in which the immune system attacks the thyroid gland. It is the most common cause of an underactive thyroid in the United States, and is treated with daily hormone replacement, usually levothyroxine. Because dosage is based on a patient's body weight, significant weight loss can impact the effect the hormones have on the patient's body and health. Below, Ivologist explains why losing weight can change the thyroid medication dose you need.
As GLP-1 prescribing increases, with 11% of U.S. adults currently taking them for weight loss purposes according to a recent Gallup poll, understanding the effects it can have on you and your current medications is only a starting point for a patient's education. The overlap is substantial. Epic Research analyzed 21,538 patients with a history of hypothyroidism who were prescribed a GLP-1 medication. Those who lost more than five pounds saw a measurable drop in their TSH, the blood marker clinicians use to judge whether a thyroid dose is still right. Those who gained weight showed no significant change.
Know the risks
When hormone levels are ignored, the body may begin to receive an excessive dosage of hormone replacement. As documented in a case study from Cureus, this may create the risk of taking in more thyroid hormones than your body needs, resulting in hyperthyroidism, an overactive thyroid. The side effects of this can include palpitations and increased heart rate, anxiety or irritability, sweating and heat intolerance, tiredness and muscle weakness, and shaking.
According to a 2025 review in Thyroid, health risks rise with age. Bone loss becomes a concern around age 50, and cardiac risk increases considerably after age 60. In older patients, this can lead to bone loss or atrial fibrillation, an uneven heart rate that could result in clots, strokes, and heart failure.
Significant weight loss may reduce levothyroxine requirements in some patients, which is why periodic reassessment is important. Published guidance recommends rechecking thyroid-stimulating hormone (TSH) when weight drops by more than 4.5 kilograms (just under 10 pounds), or if symptoms of an underactive or overactive thyroid appear. Once a level has stabilized, it is generally checked every six to 12 months. The American Thyroid Association specifically recommends reassessing the dose after large changes in body weight.
Why nobody catches it
Evidence on the relationship between GLP-1 medications and thyroid medications is still limited. This is not thought to be a direct drug interaction. Weight loss and changes in gastric emptying and absorption are the likely contributors.
The communication gap between healthcare providers focused only on their own area of specialization may also be to blame for these risks going unnoticed. A 2025 review in Cureus found that no dedicated clinical trials have yet examined GLP-1 medications in patients with autoimmune thyroid disease. As noted in a 2024 case report in the Journal of the American Pharmacists Association, patients may experience rapid weight loss, necessitating a readjustment of their thyroid medication dosage. Both that report and the Cureus case study involve patients whose thyroid had been surgically removed, and who are more sensitive to dose changes than most people with Hashimoto's. They illustrate the mechanism rather than predicting the typical experience.
Patients with Hashimoto's may already be familiar with the process of handling multiple healthcare providers, but may still be unaware of the impact that GLP-1-related weight loss can have on their thyroid. Patients should ensure they're having honest conversations with all of their healthcare providers regarding their current medication regimen, weight loss experience, and whether their thyroid dose is still suitable.
What steps to take
Candidates for a GLP-1 should not avoid them out of fear of potential side effects. Instead, it's recommended that they take the following steps before and during treatment:
1. Ask for a full thyroid panel before you begin a GLP-1, including TSH, free T4 and free T3, to have base numbers for comparison during treatment.
2. Ask the clinician who manages your thyroid how often your TSH should be rechecked while you are losing weight. Published guidance suggests rechecking after a weight loss of more than 4.5 kg, or sooner if symptoms appear.
3. Communicate your weight loss journey openly with the clinician who manages your thyroid treatment. This is the single most important thing you can do to ensure minimal complications.
4. Take your thyroid medication at a consistent time, on an empty stomach, and separate from your other medications and supplements.
5. Tell your health care provider about any side effects, including anxiety, heat intolerance, tremors, or palpitations, and don't make assumptions about their cause.
6. Protect your muscles while you lose weight. Resistance training two to three times a week, alongside adequate protein intake, helps preserve lean mass during rapid weight loss.
Did you know?
Researchers are beginning to look at whether GLP-1 medications affect thyroid autoimmunity itself, not just weight. A 2025 review in Cureus found that while these medications reduce inflammation linked to excess weight, dedicated trials in autoimmune thyroid disease have not yet been done and the connections remain unproven. Separately, a large real-world analysis reported a higher rate of autoimmune thyroiditis among GLP-1 users. The science is early and points in more than one direction, which is why it is worth discussing with your own clinician.
Patients often arrive asking whether it is the GLP-1 or the thyroid. Frequently the answer is both, and the two are being managed separately by different clinicians. Knowing that the two are connected is often the piece that was missing.
This story was produced by Ivologist and reviewed and distributed by Stacker.
